Status:
NOT_YET_RECRUITING
Early Intervention After Traumatic Exposure in Children and Adolescents
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
University Hospital, Toulouse
Centre Hospitalier Universitaire de Nīmes
Conditions:
Post-traumatic Stress Disorder (PTSD)
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
The aim of this interventional research is to evaluate the effectiveness of CFTSI in reducing post-traumatic symptoms measured using the CPC, child version, at the end of CFTSI treatment in children a...
Detailed Description
Individuals and populations worldwide are exposed to extremely high rates of maltreatment, violence, sexual and physical abuse, bullying, severe accidents, and exposure to other traumatic events (TE) ...
Eligibility Criteria
Inclusion
- Children aged between 7 and 17 years living in the family home;
- Having been exposed to a traumatic event (TE) in the last 3 months;
- Exhibiting at least one symptom on the Child Post-Traumatic Stress Checklist (CPC);
- Having at least one of the two parents available to participate in the intervention; and
- Having a good command of French, both orally and in writing.
- No participation in other therapeutic interventions aimed at treating traumatic stress symptoms is allowed during the inclusion period.
Exclusion
- Parents and/or children in acute and severe emotional distress and/or in a suicidal crisis. During the recruitment interview and signing of the consent letter, the principal investigator will ensure that the volunteer participants are not in acute suicidal crisis or in severe emotional distress requiring urgent care, which would prevent them from participating in a five-session intervention (CFTSI). This emotional distress assessment will be a clinical evaluation based on the clinician's judgment.
- Child in foster care or in the process of being placed.
- Suspected maltreatment or abuse of any kind by the parents.
- Child and/or parent with a known and/or documented intellectual disability.
- Absence of consent from either of the child's parents or the child's non-agreement to participate (appropriately obtained according to the child's developmental age, taking the time to explain the procedure and intervention to the child).
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07207018
Start Date
December 1 2025
End Date
August 1 2027
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, Herault, France, 34000